A clinical case of coinfection of COVID-19 and tropical malaria
https://doi.org/10.22625/2072-6732-2022-14-5-85-89
Abstract
The global outbreak of the new coronavirus infection COVID-19 is still ongoing, leading to coinfections such as malaria and COVID-19 and others. As evidenced by the increase in various reports of coinfections. In recent years, Uzbekistan has achieved epidemiological stability for malaria and in 2018 received an official World Health Organization certificate confirming the country’s “malaria-free” status. At the present stage during the COVID-19 pandemic, imported malaria from abroad is relevant for our republic and, therefore, there is a constant danger of renewed transmission from imported cases. In this article presented the clinical case of coinfection of COVID-19 and malaria in a patient. From the epidemiological data, the patient was a citizen of Cameroon. During treatment of coronavirus infection, the patient noted intermittent chills all over the body and sweating, clinical symptoms of tropical malaria began to appear. Microscopy of a thick drop and a thin blood smear confirmed the presence of Pl. falciparum. The patient was prescribed antimalarial therapy with mefloquine, resulting in clinical recovery.
About the Authors
L. N. Tuychiev
Tashkent Medical Academy
Uzbekistan
Uzbekistan
Tashkent
M. D. Akhmedova
Tashkent Medical Academy
Uzbekistan
Uzbekistan
Tashkent
N. U. Tadjieva
Tashkent Medical Academy; Republican Specialized Scientific-Practical Medical Center for Epidemiology, Microbiology, Infectious and Parasitic Diseases
Uzbekistan
Uzbekistan
Tashkent
J. A. Anvarov
Tashkent Medical Academy
Uzbekistan
Uzbekistan
Tashkent
U. E. Eraliev
Tashkent Medical Academy
Uzbekistan
Uzbekistan
Tashkent
A. M. Husanov
Republican Specialized Zangiota Infectious Diseases Clinic No.1
Uzbekistan
Uzbekistan
Tashkent
Sh. A. Nazirov
Tashkent Medical Academy
Uzbekistan
Uzbekistan
Tashkent
References
1. Guan W., Ni Z., Hu Y., Liang W., Ou C., He J., et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; 382 (18): 1708–20.
2. Han Y., Yang H. The transmission and diagnosis of 2019 novel coronavirus infection disease (COVID-19): A Chinese perspective. J Med Virol. 2020; 92 (6): 639–44.
3. Kyung Hee Kim, Jae Wook Choi, Juyoung Moon, Habibulla Akilov, Laziz Tuychiev, Bakhodir Rakhimov, Kwang Sung Min. Clinical Features of COVID-19 in Uzbekistan. J Korean Med Sci. 2020 Nov 23; 35 (45): e404 doi: 10.3346/jkms.2020.35.e404
4. Gupta A., Madhavan M. V., Sehgal K., Nair N., Mahajan S., Sehrawat T. S., et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020; 26 (July). Available from: doi: 10.1038/s41591-020-0968-3
5. Hogan A. B., Jewell B. L., Sherrard-Smith E., Vesga J. F., Watson O. J., Whittaker C., et al. Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in lowincome and middle-income countries: a modelling study. Lancet Glob Heal. 2020; 8 (9): e1132–41. Available from: doi: 10.1016/S2214-109X(20)30288-6
6. Lai C., Ko W., Lee P., Jean S., Hsueh P. Extra-respiratory manifestations of COVID-19. Int J Antimicrob Agents. 2020; 56.
7. Napoli P. E., Nioi M. Global Spread of Coronavirus Disease 2019 and Malaria: An Epidemiological Paradox in the Early Stage of A Pandemic. J Clin Med. 2020; 9 (4): 1138.
8. Sun J., He W. T., Wang L., Lai A., Ji X., Zhai X., et al. COVID-19: Epidemiology, Evolution, and Cross-Disciplinary Perspectives. Trends Mol Med. 2020; 26 (5): 483–95. Available from: https://doi.org/10.1016/j.molmed.2020.02.008
9. World Health Organization (WHO). Weekly Operational Update on COVID-19, 21 August 2020. 2020; (June):1–10.
10. Chanda-Kapata P., Kapata N., Zumla A. COVID-19 and malaria: A symptom screening challenge for malaria endemic countries. Int J Infect Dis. 2020; 94: 151–3.
11. Chen X., Liao B., Cheng L., Peng X., Xu X., Li Y., et al. The microbial coinfection in COVID-19. Appl Microbiol Biotechnol. 2020; 104 (18): 7777–85.
12. Ike Oluwapo Oyeneye Ajayi, Olufemi Olamide Ajumobi, Catherine Falade Malaria and COVID-19: commonalities, intersections and implications for sustaining malaria control. Pan Afr Med J. 2020; 37 (Suppl 1): Published online 2020 Sep 1. doi: 10.11604/pamj.supp.2020.37.1.25738.
13. Lev D., Biber A., Lachish T., Leshem E., Schwartz E. Malaria in travellers in the time of corona. J Travel Med. 2020; 27 (6): 1–2.
14. Mingchao Zhu, Ya Zhu, Jue Zhang, Weiping Liu A case of COVID – 19 with Imported Falciparum Malaria Infection doi: 10.21203/rs.3.rs-32935/v1.
15. Muhammad Junaedi, Sudirman Katu, Muh Ilyas, Numan Daud, Sahyuddin Saleh, Haerani Rasyid, Nurjannah Lihawa. Case Report: Covid-19 And Severe Malaria Co-Infection European Journal of Molecular & Clinical Medicine, Volume 07, Issue 08, 2020. Р. 961-968.
16. Popovich O. O., Moroz L. V., Chabanov F. A., Vzhecon T. V., Slepova I. G. Aktual’naya Infektologiya – 2017. – 5 (4), 189-194. doi: 10.22141/2312-413x.5.4.2017.115733 (in Russian)
17. Aminov Z. Z., Israilova S. B., Kurbanov A. A., Tjo I. L. Akademija – 2020. – 99-101. URL: https://cyberleninka.ru/article/n/sovremennye-aspekty-situatsii-po-malyarii-v-uzbekistane.pdf. (in Russian)
18. Susila M., Parwati T. Management Malaria with Jaundice. Malar Contr Elimin. 2016; 5 (2): 1175.
19. Parasitic diseases of humans (protozoa and helminthiasis). Edited by V. P. Sergiev, Yu. V. Lobzin, S. S. Kozlov. 3rd edition, revised and supplemented. – St. Petersburg: Folio, 2016. – 639 p.
20. Lampah D. A., Yeo T. W., Malloy M., Kenangalem E., Douglas N. M., Ronaldo D., et al. Severe malarial thrombocytopenia: A risk factor for mortality in Papua, Indonesia. J Infect Dis. 2015; 211 (4): 623–34.
21. Xu P., Zhou Q., Xu J. Mechanism of thrombocytopenia in COVID-19 patients. Ann Hematol. 2020; 99 (6): 1205–8.
Review
For citations:
Tuychiev L.N., Akhmedova M.D., Tadjieva N.U., Anvarov J.A., Eraliev U.E., Husanov A.M., Nazirov Sh.A. A clinical case of coinfection of COVID-19 and tropical malaria. Journal Infectology. 2022;14(5):85-89. (In Russ.) https://doi.org/10.22625/2072-6732-2022-14-5-85-89
Views:
654
.png)
.png)
Email this article 